Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03819231 · ClinicalTrials.gov registry record · Phase 2
Mindfulness Training Plus Oxytocin Effects on Smoking Behavior
A Phase 2 study, sponsored by University of Southern California.
- Terminated
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT03819231 is a Phase 2 study that was terminated before completion, run by University of Southern California. The registered enrollment target is 20 participants.
The verdict
NCT03819231, a Phase 2 study, was terminated before completion, sponsored by University of Southern California.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the effects of mindfulness training and a drug called oxytocin on smoking.
Interventions
- DRUG Oxytocin
- BEHAVIORAL Mindfulness
- DRUG Saline Solution
- BEHAVIORAL Sham mindfulness
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2018-10-10 |
| Est. Completion | 2023-12-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03819231
The ClinicalTrials.gov registry entry for NCT03819231 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Oxytocin is the first listed.
NCT03819231 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03819231 about?
NCT03819231 is a clinical study titled "Mindfulness Training Plus Oxytocin Effects on Smoking Behavior". The purpose of this study is to examine the effects of mindfulness training and a drug called oxytocin on smoking.
What is the current status of trial NCT03819231?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2018-10-10. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT03819231?
The interventions under investigation include: Oxytocin (DRUG), Mindfulness (BEHAVIORAL), Saline Solution (DRUG), Sham mindfulness (BEHAVIORAL).
Who is sponsoring clinical trial NCT03819231?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.